Colonoscopy and colorectal cancer screening in the year of the pandemic

ABSTRACT

Professor Michal Kaminski is a professor of gastroenterology at the Maria Sklodowska-Curie Me-morial Cancer Center and Institute of Oncology, in Warsaw, Poland. Since his landmark study, published on the The New England Journal of Medicine in 2010, which demonstrated the association between the quality of colonoscopy (namely, the adenoma detection rate) and the risk of interval colorectal cancer, he has published over a hundred peer-reviewed articles, mainly focused on colonoscopy and colorectal cancer screening. His main clinical and research activities include population screening methods and surveillance for colorectal cancer, quality and advanced tech-nical developments in colonoscopy, and the treatment of colorectal polyps and the early stages of intestinal cancer. Today, he is considered a leading international expert in this field. As a member of the Governing Board of the European Society of Gastrointestinal Endoscopy (ESGE), he has been actively involved in the development of many ESGE guidelines. In this interview with Professor Kaminski, the impact of SARS-COV2 pandemic on colorectal screening and the new technological innovations in colonoscopy will be discussed.